Johnson & Johnson's $2B Investment in U.S. Biopharma Manufacturing

The Department of Health and Human Services announces plans to start an advisory committee to help reimagine federal health insurance programs. A federal court ruling strikes down a Medicare Advantage marketing rule introduced during the Biden administration. And, Johnson & Johnson commits to a major investment aimed at strengthening domestic pharmaceutical manufacturing. Those stories—and more—on today’s episode of the Gist Healthcare Podcast.

---

Hosted on Acast. See acast.com/privacy for more information.